Skip to content
Breakthrough Therapies NTRK With Robert Doebele episode artwork

Mar 15, 2022 32 min

Breakthrough Therapies NTRK With Robert Doebele

from Lung Cancer Considered Hosted by IASLC

In this episode of Lung Cancer Considered, host Dr. Narjust Duma talks with Dr. Robert C. Doebele, Co-Founder and Chief Scientific Officer, Rain Therapeutics about NTKR gene fusions, including recent and emerging breakthrough therapies.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Breakthrough Therapies NTRK With Robert Doebele

0:00 32:59

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Lung Cancer Considered?

This episode is 32 minutes long.

When was this Lung Cancer Considered episode published?

This episode was published on March 15, 2022.

Can I download this Lung Cancer Considered episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.